IDENTIFIKASI SENYAWA AKTIF DAUN PLETEKAN (Ruellia tuberosa L.) DENGAN MENGGUNAKAN GC-MS
on
Authors:
Ida Ayu Nopiari, Ni Putu Adriani Astiti, Ngurah Intan Wiratmini
Abstract:
“ABSTRACT The use of traditional medicines in human therapies has been claimed to be much safer than that of synthetic medicines with many negative side effects. Pletekan plant (Ruellia tuberosa L.) has been used empirically for years as an antidiabetic as its leaves contain poly phenolic compounds with the ability to stimulate beta cells of the pancreas so that its capability to produce insulin improved. The main objective of our research was to identify active compounds contained in Ruellia tuberosa L. leaves extracted with ethanol. Fractionation of these active compounds was conducted by applying column and thin layer chromatography using Dichlorometan and Ethylacetat with a ratio of 6:3 as eluent. Each active compound resulted from fractionation was identified using GC-MS analysis. The results showed that four active compounds (Hexadecanamide, 9-Octadecenamide, (Z), Octadecenamide and 1,2-Benzenedicarboxylic acid were identified in this analysis. Keywords: Ruellia tuberosa L., identification of active compounds.”
Keywords
Ruellia tuberosa L., identification of active compounds.
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/simbiosis/full-28755
Published
2021-11-09
How To Cite
NOPIARI, Ida Ayu; ADRIANI ASTITI, Ni Putu; INTAN WIRATMINI, Ngurah. IDENTIFIKASI SENYAWA AKTIF DAUN PLETEKAN (Ruellia tuberosa L.) DENGAN MENGGUNAKAN GC-MS.SIMBIOSIS, [S.l.], v. 4, n. 2, feb. 2017. ISSN 2656-7784. Available at: https://jurnal.harianregional.com/simbiosis/id-28755. Date accessed: 28 Aug. 2025.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol 4 No 2 (2016)
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback